Amelia Barnett

Internal Medicine

330 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

Days spent with healthcare contact by patients with metastatic castrate resistant prostate cancer in the last year of life.

Days spent with healthcare contact by patients with metastatic castrate resistant prostate cancer in the last year of life.

Journal: The oncologist

Published: October 29, 2024

Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation.

Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation.

Journal: Blood advances

Published: July 17, 2023

Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion.

Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion.

Journal: Journal of medicinal chemistry

Published: April 08, 2021

MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage.

MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage.

Journal: Cancer cell

Published: February 11, 2020

Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

Journal: Nature

Published: January 18, 2018

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

Journal: Nature

Published: September 12, 2016

Showing 1-6 of 6

Last Updated: 09/26/2026